Search Page

1

Cite

Share

Cardiovascular events in patients with COPD: TORCH study results.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Crim C, Willits LR, Yates JC, Vestbo J; TORCH Investigators. Calverley PM, et al. Among authors: willits lr. Thorax. 2010 Aug;65(8):719-25. doi: 10.1136/thx.2010.136077. Thorax. 2010. PMID: 20685748 Clinical Trial.

Cite

Share

2

Cite

Share

Reported pneumonia in patients with COPD: findings from the INSPIRE study.

Calverley PMA, Stockley RA, Seemungal TAR, Hagan G, Willits LR, Riley JH, Wedzicha JA; Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators. Calverley PMA, et al. Among authors: willits lr. Chest. 2011 Mar;139(3):505-512. doi: 10.1378/chest.09-2992. Epub 2010 Jun 24. Chest. 2011. PMID: 20576732 Clinical Trial.

Cite

Share

3

Cite

Share

Adherence to inhaled therapy, mortality and hospital admission in COPD.

Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Vestbo J, et al. Among authors: willits lr. Thorax. 2009 Nov;64(11):939-43. doi: 10.1136/thx.2009.113662. Epub 2009 Aug 23. Thorax. 2009. PMID: 19703830 Clinical Trial.

Cite

Share

4

Cite

Share

Withdrawal from treatment as an outcome in the ISOLDE study of COPD.

Calverley PM, Spencer S, Willits L, Burge PS, Jones PW; IOSLDE Study Group. Calverley PM, et al. Among authors: willits l. Chest. 2003 Oct;124(4):1350-6. doi: 10.1378/chest.124.4.1350. Chest. 2003. PMID: 14555565 Clinical Trial.

Cite

Share

5

Cite

Share

An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease.

Lomas DA, Lipson DA, Miller BE, Willits L, Keene O, Barnacle H, Barnes NC, Tal-Singer R; Losmapimod Study Investigators. Lomas DA, et al. Among authors: willits l. J Clin Pharmacol. 2012 Mar;52(3):416-24. doi: 10.1177/0091270010397050. Epub 2011 Nov 16. J Clin Pharmacol. 2012. PMID: 22090363 Clinical Trial.

Cite

Share

6

Cite

Share

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC, Vestbo J. Crim C, et al. Among authors: willits lr. Eur Respir J. 2009 Sep;34(3):641-7. doi: 10.1183/09031936.00193908. Epub 2009 May 14. Eur Respir J. 2009. PMID: 19443528 Free article. Clinical Trial.

Cite

Share

7

Cite

Share

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.

Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. Ferguson GT, et al. Among authors: willits lr. Chest. 2009 Dec;136(6):1456-1465. doi: 10.1378/chest.08-3016. Epub 2009 Jul 6. Chest. 2009. PMID: 19581353 Clinical Trial.

Cite

Share

8

Cite

Share

Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience.

Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, Yates JC, Anderson JA, Willits LR, Wise RA; Investigators of the TORCH Study. Celli B, et al. Among authors: willits lr. Am J Respir Crit Care Med. 2011 Feb 1;183(3):317-22. doi: 10.1164/rccm.201004-0665OC. Epub 2010 Sep 2. Am J Respir Crit Care Med. 2011. PMID: 20813884 Clinical Trial.

Cite

Share

9

Cite

Share

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J. Jenkins CR, et al. Among authors: willits lr. Respir Res. 2009 Jun 30;10(1):59. doi: 10.1186/1465-9921-10-59. Respir Res. 2009. PMID: 19566934 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations.

Jones PW, Willits LR, Burge PS, Calverley PM; Inhaled Steroids in Obstructive Lung Disease in Europe study investigators. Jones PW, et al. Among authors: willits lr. Eur Respir J. 2003 Jan;21(1):68-73. doi: 10.1183/09031936.03.00013303. Eur Respir J. 2003. PMID: 12570111 Free article. Clinical Trial.

Cite

Share